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A new unique dual-structure hydrogel composed of nanostructures of amphiphilic chitosan (CHC) 
dispersed in a sodium alginate matrix (SAL) is presented. The successful creation of the composite is 
based on combining chitosan and sodium alginate without precipitation or agglomeration, which has not 
been previously reported. The CHC/SAL composite gels presents a number of properties making them 
attractive for biomedical applications, in particular as implantable depot gels or in dermal applications. 10 
The gels are shown to form rapidly upon exposure of the combination solution to Ca2+ containing gelation 
medium. The formed gels have storage moduli similar to soft tissue and displays shear reversible gelation 
with fast recovery of mechanical properties, in addition to self healing capability at certain compositions. 
The gels exhibit moderate swelling in deionized water and low swelling in simulated body fluid and cell 
culture media. The drug release from the composite gels is demonstrated using the hydrophobic drug all-15 
trans retinoic acid, which is used in cancer and skin disorder therapies. The drug release initially occurs 
through a Fickian mechanism for a fraction of the loaded drug, where the fraction released during this 
process depends on release media and gel composition. A large fraction of loaded drug can be retained for 
long term depot drug delivery. Furthermore, the CHC/SAL gels are determined to have low toxicity and 
skin irritation. 20 
Introduction 
With the rapidly evolving knowledge in the biomedical field of 
today there is increasing demand for materials that can meet the 
needs of new applications. One specific application is depot 
systems for sustained drug delivery. Depot systems hold the 25 
benefit of providing sustained drug release over long times, as 
well as being able to provide local therapeutic effect.1-3 There are 
several challenges in the design of materials to be used in such 
systems. The materials should allow for high loading of 
hydrophobic drugs and control over the release process.4 In the 30 
case of implantable depot systems the administration should be 
easy, as for injectable in vivo gelling formulations. Furthermore, 
the materials should be biocompatible in their given application. 
Obviously, the materials used should be non toxic and non irritant 
for transdermal applications. For implantable devices the 35 
mechanical properties of the device are also of great importance, 
it has been stated that “the mechanical property of the interface 
between an implant and its surrounding tissues is critical for the 
host response and the performance of the device”.5 
 One way to overcome the low solubility of hydrophobic drugs 40 
is to make use of amphiphilic copolymers or modified polymer 
micelles, such polymer materials tend to self-assemble into 
nanoscale micelle-like structures, having core-shell architecture 
in aqueous solution.6-8 This structure provides the ability to 
encapsulate and release hydrophobic compounds. In addition, 45 
such drug carriers can commonly be designed to be 
biocompatible and/or biodegradable.6, 9, 10 This kind of nano 
carriers can be effectively utilized in designing hydrogel systems 
for release of drugs with low solubility. Gou et al. presented the 
idea to combine a nanoscale carrier and a hydrogel matrix into a 50 
composite dual structure delivery system for hydrophobic drug 
release,11 inspired by similar reports on micro- and nano-particles 
in thermo-sensitive hydrogel composite drug delivery systems.12, 
13 
 The mechanical properties, and in particular the storage 55 
modulus, of a gel matrix is dependent on the crosslink density.14 
However, for composites where particle additives are dispersed in 
a gel network the mechanical properties can be significantly 
different from the pure matrix, depending on additive 
concentration, modulus and the extent of additive-matrix 60 
interaction.15-17 When the additives are hard fillers two ultimate 
cases can be discriminated:18 (1) No interaction between the 
dispersed particles; this causes a decrease in gel modulus with 
increasing polymer volume fraction. (2) A strong interaction 
between the fillers and the matrix; this causes an increase in 65 
modulus of the gel with the increasing polymer volume fraction if 
the filler material is harder than the gel matrix. For additives 
having sizes similar to the matrix network the effects are more 
complex, and aggregation of the additive is an important factor.19 
Nanofillers having strong interaction with the matrix have been 70 
reported to increase the storage modulus of the composite far 
more than expected from traditional filler theory.20, 21 On the 
other hand, alginate gels prepared using glycerol or low 
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molecular weight dextran as additives displayed an increased 
viscosity in the gel liquid phase but did not show any changes in 
storage modulus. However, for high molecular weight dextran the 
storage modulus was significantly lowered,22, 23 this was 
explained by that the high molecular weight dextran disturbed the 5 
crosslink structure of the alginate. 
 Alginate and chitosan are two natural polymers that are 
biodegradable, biocompatible, non-toxic, and mucoadhesive.24 
Because of those desirable properties they are commonly used 
and have great future potential in biomedical applications, such 10 
as; drug delivery systems, tissue engineering scaffolds, and in 
food industry as stabilizers, thickeners and gelling agents.3, 24-30 
Alginate is a linear block copolymer composed of 
homopolymeric blocks of (1-4) linked α-L-guluronate (G) and β-
D-mannuronate (M) residues.24, 31, 32 The relative number of M- 15 
and G-blocks depends on the origin of alginate. One of the most 
important properties of alginate, with regard to biomedical 
applications, is the ability to form gels by interaction with 
divalent cations such as Ca2+. The gelation and cross-linking of 
the alginate is mainly achieved by interaction between the 20 
carboxyl groups and the divalent cations, and the stacking of 
these G-blocks to form the characteristic egg-box structure.24, 33-35 
In addition, the highly swelling sodium alginate form (SAL) also 
has the ability to form gels by the exchange of sodium ions from 
the G-blocks with divalent cations. Amphiphilically modified 25 
chitosan, named carboxymethyl-hexanoyl chitosan (CHC), has 
previously been synthesized in an aqueous system without the aid 
of surfactants, organic solvents, emulsion phases, or template 
cores, to form a hollow nanocapsules in water.27, 28, 36 The CHC 
has excellent encapsulating efficiency for hydrophobic drugs due 30 
to its self-assembly properties and hydrophobic domains. 
 In this study, amphiphilic chitosan was synthesized and used 
as a hydrophobic drug carrier in an alginate hydrogel matrix. 
Composite gels of sodium alginate and micelle-like amphiphilic 
carboxymethyl-hexanoyl chitosan nanoparticles were prepared in 35 
various compositions, varying the SAL and CHC content, the 
amount of glycerol in the gel forming solution and the amount of 
calcium chloride in the gelation media. The composite gels were 
characterized with regard to a number of properties such as; 
gelation time, equilibrium swelling, rheological properties, self-40 
healing behaviour and release of the hydrophobic drug all-trans 
retinoic acid. The dependences of the gel properties on the 
compositions of the hydrogels were then discussed. 
Materials and methods 
Materials 45 
2-propanol, hexanoyl anhydride, all-trans-Retinoic acid, Chitosan 
(Mw=215000 g/mol, deacetylation degree=85-90 %), 
chloroacetic acid, sodium alginate (low viscosity, 250 cps for 2 % 
at 25℃) and sodium hydroxide was purchased from Sigma-
Aldrich. Calcium chloride was acquired from Showa. Glycerol 50 
was purchased from Riedel-de Haën. Minimal essential medium 
(α-MEM) was prepared with components bought from Gibco and 
1.5x simulated body fluid (1.5BF) was prepared in-house. 
Preparation of amphiphilic chitosan/sodium alginate 
combination solutions 55 
Amphiphilic chitosan (CHC) was prepared through both 
hydrophilic carboxymethyl and hydrophobic hexanoyl 
substitutions, as previously described 27, 28. CHC solution (2 % 
w/w) was prepared in a vial, using sodium hydroxide solution to 
adjust the pH value to slightly alkaline (pH = 7.5-8.5). Sodium 60 
Alginate (SAL) solutions were prepared with different 
concentrations (1, 2, 3, and 4 % w/w). CHC/SAL combination 
solutions with different compositions were formed by mixing 
CHC solution containing varying amount of glycerol (0, 10, or 20 
% w/w) with an equal volume of SAL solution. 65 
Hydrogel formation 
The composite hydrogels were formed in the presence of various 
calcium ion concentrations as follows; CHC/SAL combination 
solution (2 ml) in a glass Petri dish was submerged into calcium 
chloride solution (50 ml, 1, 2, or 3 % w/w) at room temperature. 70 
The time to form a gel (designated as gelation time) was 
determined using a vial tilting method, where no flow within 1 
minute of inverting the vial was the criterion for gel state 37, 38. 
Rheological measurements 
Rheological characterization of the CHC/SAL composite 75 
hydrogels was performed on a strain-controlled rheometer 
(Rheological Scientific, ARES instrument) using parallel-plate 
fixture. Olive oil was used to cover the surface of the composite 
hydrogels in order to avoid water evaporation during the analysis. 
The rheological properties of the CHC/SAL composite hydrogels 80 
were characterized by strain sweep tests (γ = 0.01 ~100 %) and 
small deformation tests (γ = 0.015 ~7 %) using a fixed frequency 
(ω = 10 rad / s) and a temperature of 37 ○C. The gap at the apex 
of the parallel-plate was set to be 2 mm and samples were placed 
between the parallel-plate and the platform. To investigate the 85 
recovery properties of the samples after exposure to high shear 
strain, the following program was applied: γ = 0.1 % (100 s) →γ 
= 100 % (100 s) →γ = 0.1 % (200 s) →γ = 100 % (200 s) →γ = 
0.1 % (300 s). 
Investigation of self-healing capability 90 
The self-healing capability of the composite hydrogels was 
investigated as follows; two types of samples were prepared, one 
was coloured by Trypan blue and the other was a pure CHC/SAL 
hydrogel. The samples were cut into a size of 3 × 1 × 0.5 cm and 
the freshly produced surfaces of two samples with different 95 
colour were brought together within one minute. After allowing 
healing to proceed for 30 minutes to one hour, the healed 
composite hydrogel bridge was suspended horizontally and 
vertically. 
Equilibrium Swelling 100 
To determine the equilibrium swelling under different conditions, 
gels made from CHC/SAL (about 2 g) were lyophilized and 
weighted (Wd). The dried hydrogels were immersed in di-water, 
medium (α-MEM+10% FBS), or 1.5SBF for 1 day until 
equilibrium swelling state had been attained. After removal of 105 
water from the surface of the swollen hydrogels, the samples 
were weighted (Ws). The equilibrium swelling degree (ESD) was 
calculated using the following equation: 
 ESD = (𝑊𝑠 − 𝑊𝑑) 𝑊𝑑⁄  (1) 
In vitro release study of retinoic acid 110 
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Retinoic acid released from varying formulations of CHC/SAL 
composite hydrogels was determined in different release 
environments. Drug loaded gels were prepared as follows; a stock 
solution of retinoic acid was prepared by dissolving of retinoic 
acid (100 mg) in isopropanol (50 ml). The stock solution was 5 
diluted to achieve the final retinoic acid concentration (100 μg / 
ml), subsequently CHC was added (2 % w/w). Composite 
hydrogels with different compositions were then prepared as 
described above. To investigate the release profiles for the drug-
loaded CHC/SAL composite hydrogels, samples were submerged 10 
in di-water or 1.5SBF (3 ml). At predetermined times samples 
were extracted (1 ml) and centrifuged at 12000 rpm for 5min. 
Subsequently, the drug concentration in the supernatant was 
determined from the absorbance at 340 nm using a UV-Vis 
spectrophotometer (Evolution 300, Thermo scientific). The 15 
extracted volume was replaced with an equal volume of fresh 
dissolution medium, which was accounted for in the release 
calculations. 
Cytotoxicity Assay 
WS1 human fetal skin fibroblast cell lines (BCRC number: 20 
60300) were grown in minimum essential medium (MEM) with 
FBS (10 %), non-essential amino acids (0.1 mM), and sodium 
pyruvate (1.0 mM). The cells were incubated at 37 ○C, in a CO2 
containing (5 %) humidified atmosphere. The culture medium 
was changed every two to three days. For all experiments, cells 25 
were harvested from sub-confluent cultures using trypsin and 
were re-suspended in fresh complete medium before plating. To 
investigate the in vitro cytotoxicity of the CHC/SAL composite 
gel, viability of human WS1 fetal skin fibroblasts was analyzed 
with the MTT assay. CHC/SAL gels were formed from 30 
combination solution (0.5 ml) with the weight ratios 
CHC/SAL/glycerol = 1/1.5/0 prepared by exposure to CaCl2 (2 % 
w/w). Two kinds of samples, one loaded with retinoic acid (100 
μg / ml) and one without drug (pure gel), were prepared in 24-
well plates. Briefly, 3×104 cells were plated to allow the cells to 35 
attach at 37 ℃ in an atmosphere with CO2 (5 %). After 1 and 2 
days incubation, MTT/medium (1:9) combination solution (100 
μl) was added and incubation was continued for another 4 hours. 
Then, DMSO was added to solve the precipitate, which formed 
from the reaction between MTT reagents and live cells, and the 40 
solution was transferred to a 96-well plate. The result solution 
absorbance values were determined at 595 nm using a Sunrise 
absorbance microplate reader (DV990/BV4, GDV Programmable 
MPT Reader). 
In vivo skin irritation test 45 
The Draize model and its modification such as “UNI EN 
ISO10993-10:1996” and “USP Biological Tests” are generally 
used to examine the degree of skin primary irritation utilizing 
healthy rabbits 39-41. Following the Draize model, the back of 
healthy male New Zealand white rabbits were narrowly clipped 50 
free of fur with an electric clipper 4 hours before application of 
samples. Each rabbit (n = 6) received six parallel epidermal 
abrasions with a sterile needle (26G 1/2 0.45 × 13 mm) at one test 
site while the skin at the opposite site remained intact. Samples 
were prepared by coating gel (0.5 ml, weight ratios 55 
CHC/SAL/glycerol = 1/0.5/0 or 1/1.5/0, prepared by exposure to 
2 % w/w CaCl2) on fixed size gauzes with 1”×1” (2.54 × 2.54 
cm) square. The patches were covered with a non-reactive tape 
and the entire test site was swathed with a non-occlusive 
bandage. After a 24 hour treatment, the bandage and gauze 60 
sample were removed. The test sites were swabbed with 
physiological saline solution to remove any remaining test article 
residue. The used evaluation procedure was the one adopted in 
the U.S. Federal Hazardous Substance Act (FHSA) 42, and is 
described in supporting information. 65 
 At times 24, 48, and 72 hours after sample application, the test 
sites were evaluated for dermal reactions, defined as erythema 
and edema, according to the Draize – FHSA scoring system 
(supporting information). The score of primary irritation of the 
test was calculated for various dosages. The Primary Irritation 70 
Index (PII) was calculated as the arithmetical mean 40, 41: 
 PII =
∑ 𝐸𝑟𝑦𝑡ℎ𝑒𝑚𝑎 𝑎𝑛𝑑 𝐸𝑑𝑒𝑚𝑎 𝑔𝑟𝑎𝑑𝑒 𝑎𝑡 24,48 𝑎𝑛𝑑 72ℎ
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛𝑠
 (2) 
and the evaluation of PII was performed according to Table 1. 
Table 1 Evaluation of Primary Irritation Index 
Index Evaluation 
0.00 No irritation 
0.04 – 0.99 Irritation barely perceptible 
1.00 – 1.99 Slight irritation 
2.00 – 2.99 Mild irritation 
3.00 – 5.99 Moderate irritation 
6.00 – 8.00 Severe irritation 
 75 
Results and discussion 
To the authors’ knowledge, there has to date been no reported 
method to provide a steady combination solution with chitosan 
and sodium alginate. This is owing to two main reasons: (1) the 
opposite charge of the polymers leads to electrostatic attraction 80 
promoting aggregation; (2) the property that sodium alginate 
(SAL) forms an acid gel by the addition of acidic chitosan 
solution.24 Here, amphiphilic carboxymethyl-hexanoyl chitosan 
(CHC) was used because of its proven potential as a hydrophobic 
drug carrier, utilizing self-assembly.27 To prevent aggregation 85 
and acid gel formation upon combination of the CHC and SAL 
solutions the CHC solution was adjusted to slightly alkaline 
(pH=7.5~8) prior to mixing. Ordinarily, an acidic chitosan 
solution would rapidly produce a hydrated precipitate upon 
addition of a strong base, such as NaOH. This is due to the 90 
reduced positive charge density along the chitosan chains (NH3+).  
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Scheme 1 Molecular structure of modified amphiphilic chitosan (CHC) and sodium alginate (SAL) and the suggested crosslinked network structure after 
gelation by CaCl2 rich medium.
The neutral chains would interact strongly through hydrogen 
bonding and hydrophobic interactions between chains. There was 5 
no hydrated precipitate but only a little agglomerate when the 
amphiphilic CHC solution was adjusted to slightly alkaline by 
addition of NaOH. This because of the steric effect from the long 
hexanoyl groups prevents hydrogen bonding between CHC 
chains,43 as shown in Scheme 1, and because the self-assembly 10 
property into a micelle structure may further reduce the 
aggregation tendency. At the set pH value, the zeta potential of  
the CHC solution would be close to neutral, as the isoelectric 
point was determined to be about 7.5. The fact that the modified 
chitosan is neutrally charged, and soluble at slightly alkaline pH, 15 
allows for the successful combination with sodium alginate. 
Indeed, no aggregation or gelation was observed upon forming 
the CHC/SAL combination solution.  
 Below the properties of hydrogels prepared from CHA/SAL 
combination solutions with different compositions is discussed 20 
with special focus on realistic biomedical applications. 
Hydrogel formation 
SAL is well known to form a strong gel upon exposure to calcium 
ions. The calcium cross-links the alginate chains by replacing 
sodium ions with calcium ions to form the well known “egg box” 25 
structure through electrostatic forces between guluronic groups 
expressed on different alginate chains and bridging calcium 
ions.22 Therefore, gelation of the CHC/SAL combination 
solutions was induced by exposure to CaCl2 solution (gelation 
media). The CHC concentration in the combination solution was 30 
above the aqueous critical aggregation concentration, as such the 
CHC should exist in self assembled micelle like structures, 
having diameters in the range 50-200 nm.36, 44 Thus the structure 
of the formed composite gels is proposed to be a crosslinked 
alginate matrix with embedded nano micelles. Scheme 1 shows 35 
the structure of CHC and SAL, as well as schematic drawing of 
the proposed composite gel structure. 
 The gel formation process and the gelation rate of the 
composite hydrogels were observed at room temperature. The 
gelation time could be adjusted by varying SAL and CaCl2 40 
concentration, with the fastest gelation time being close to 
instantaneous and the longest being about 10 s (Table 2). As an 
example, the gel with the weight ratios CHC/SAL/glycerol = 
1/1/5, prepared by exposure to 1 % w/w CaCl2 solution formed a 
gel in roughly 10 s. 45 
Table 2 Gelation time (s) depending on SAL concentration in the 
combination solution and Ca2+ concentration in the gelation medium. 
 1 % SAL 1.5 % SAL 2 % SAL  
1% Ca2+ 10 5 3  
2% Ca2+ 3 < 1 < 1  
3% Ca2+ 1 < 1 < 1  
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Fig. 1 Rheological properties of CHC/SAL composite hydrogels. (a) Large strain sweep (γ = 0.01 ~ 100 %) for gels having weight ratios 
CHC/SAL/glycerol = 1/1.5/0 prepared by exposure to 3 % w/w CaCl2. (b) Continuous step strain measurement (γ = 0.1 and 100 %) for hydrogel with the 
weight ratios CHC/SAL/glycerol = 1/1.5/0. Small deformation tests (γ = 0.015 ~ 7 %) for samples with weight ratios; (c) CHC/SAL/glycerol = 1/1.5/5 
prepared using varying CaCl2 concentration in the gelation medium and (d) SAL/glycerol = 1.5/0 having varying CHC content, prepared by exposure to 2 5 
% w/w CaCl2. 
By increasing the SAL concentration from 1 to 2 % w/w, keeping 
the other conditions constant, the gelation time displayed an 
obvious decrease from 10 to 3 s. With increasing ratios of Ca2+ in 
the gelation media, the gelation time was greatly decreased. In 10 
fact, the gelation appeared to occur almost immediately for all but 
the samples with the lowest SAL concentration. The extremely 
quick gelling makes the CHC/SAL system a great candidate for 
injectable gel applications, where the combination solution could 
be co-injected with calcium containing gelation medium 15 
Rheological properties 
The rheological properties of hydrogels are of great importance in 
determining their performance in different applications and under 
different conditions; in addition it gives information about the 
structure of the gels. CHC/SAL composite hydrogels were 20 
subjected to strain sweep tests, monitoring the storage (G’) and 
loss modulus (G”). As shown in Fig. 1a, there was a gel-liquid 
transition point (tanδ = G’ / G’’ = 1; γg = 17.8 %) indicating a 
breakdown of the gel state to a quasi-liquid state above a 
threshold strain. Reversible shear induced breakdown has 25 
previously been reported for pure alginate32 and chitosan45 gels. 
To investigate if this property was retained for CHC containing 
gels the sample with the weight ratios CHC/SAL/glycerol = 
1/1.5/0, prepared by exposure to 3 % w/w CaCl2, was 
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investigated for shear reversibility. It was found to rapidly 
recover to its original gel state after a high shear strain induced 
structural breakdown, as shown in Fig. 1b. When high shear 
strain was applied, with the corresponding high shear stress (γ = 
100 %) and (ω= 10 rad /s ), the G’ values decreased from 18 kPa 5 
to 0.21 kPa resulting in a quasi-liquid state (tanδ ≈ 5). However, 
when the strain amplitude was decreased (γ = 0.01 %) at the same 
frequency, G’ instantly recovered its initial value and the system 
returned to a quasi-solid (gel) state (tanδ ≈ 0.2). In fact, the shear 
recovery of the composite gels was extremely fast compared to 10 
pure alginate32, 46 and chitosan45 gels, for which the reported shear 
recovery occur over a longer period of time. 
 In Fig. 1c, the effect of calcium chloride concentration in the 
gelation medium (1, 2, and 3 % w/w) is shown for samples with 
the weight ratios CHC/SAL/glycerol = 1/1.5/5, as determined by 15 
small deformation test. All samples displayed a plateau region in 
their moduli below the same critical strain (γc) at which the 
polymeric system starts to display nonlinear viscoelastic 
behaviour (gel structure breaks up).45 When the strain was larger 
than γc, there was a rapid decrease of the storage modulus. The 20 
fact that all sample preparations displayed G’ values larger than 
G” at small strains clearly proves the gel character under those 
conditions. The results show that G’ and G” values increased 
with the increasing concentration of CaCl2 in the gelation 
medium. The modulus values of hydrogels prepared using 3 % 25 
w/w CaCl2 in the gelation medium was almost about 1.2 times 
larger than using 2 % w/w CaCl2 and 2.4 times larger than using  
1 % w/w CaCl2. According to rubber elasticity theory the 
correlation between storage modulus and the network crosslink 
density can be described by the equation:47 30 
 𝐺 = 𝑔𝑅𝑇𝑁 (3) 
where G is the network equilibrium shear modulus; g is a 
constant, nearing 1.0 for incompressible materials; R is the gas 
constant; T is the absolute temperature; N is the number of 
elastically active network chains per unit volume for a network. 35 
Although this Eq. 3 is derived for networks of Gaussian chains, it 
can be applied to real polymer materials to provide an indication 
of network structure from shear modulus behaviour.48, 49 Segeren 
et al. found several features of alginate gels formed by Ca2+ to be 
consistent with rubber elasticity theory.50 Thus, it can be 40 
concluded that increasing Ca2+ concentration in gelation medium 
resulted in a rise of crosslinking density with the corresponding 
increase in storage modulus. 
 In this study, it was also crucial to elucidate the role of CHC 
nanoparticles in determining the gels properties, in addition to 45 
providing a platform for delivery. As seen from Fig. 1d the 
presence of CHC nanoparticles decreased the storage modulus 
compared to pure alginate gels. It is known that particle additives 
alter the storage modulus depending on the interactions between 
additive and network chains18, 51 For calcium alginate gels Zhang 50 
et al. found that the addition of low molecular weight (MW) 
dextran or glycerol prior to gelation had no significant effect on 
storage modulus. In contrast, gels to which high MW dextran was 
added displayed a decrease of the storage modulus, as compared 
to pure calcium alginate gels.22 This was explained by the steric 55 
effects of the high MW dextran disturbing the crosslinking 
structure of the alginate gels. The same explanation seems  
Table 3 Critical strain and cohesion energies for various preparations of 
CHC/SAL hydrogels (weight ratio = 1/1.5). 
Glycerol (%)a  γc (%) Ec(kJ / m
3)b  Ca2+ (%)c γc (%) Ec (kJ / m
3)b 
0 1.55 20.1 ± 0.06 1 1.55 13.3 ± 0.07 
5 1.55 29.7 ± 0.05 2 1.55 24.2 ± 0.08 
10 1.55 35.7 ± 0.04 3 1.55 29.7 ± 0.05 
a Percent glycerol in the combination solution, gels prepared by exposure 60 
to gelation medium with 3 % CaCl2. 
b ± indicates maximum deviation 
from mean. c The Ca2+ percent is concentration in gelation medium, the 
combination solution contained 5 % glycerol. 
plausible for the lower storage modulus of the composite gels in 
this study. The CHC nanoparticles inside the gel structure would 65 
appear as steric hindrances, separating the alginate chains, 
resulting in decreased crosslink density with the associated 
decrease of storage modulus. 
  Interestingly, it was found that the presence of glycerol in the 
CHC/SAL composites increased the storage modulus. This is in 70 
contrast to what has previously been reported for pure calcium 
alginate gels.22 Small deformation tests for samples prepared with 
varying glycerol contents (fixed weight ratios CHC/SAL = 1/1.5 
and 3 % w/w CaCl2 in the gelation medium) revealed that the G’  
values for samples prepared with 10 % glycerol was 1.2 times 75 
larger than if prepared with 5 % glycerol and 1.75 times larger 
than gels prepared without glycerol (See Supplementary material, 
comparisons made at γ = 0.245 %). It seems likely that in the 
composite gels the glycerol act as a hydrogen bonding connector 
between the otherwise non-interacting CHC nanoparticles and 80 
alginate chains, as well as between CHC nanoparticles. This 
hydrogen bridging should act crosslinking, and thus increase the 
storage modulus of the gels. 
 All of the investigated gel formulations displayed the same 
critical strain, which together with the storage modulus can be 85 
correlated to the gel cohesion energy as:45, 52 
 𝐸𝑐 = ∫ 𝐺𝑐
′𝛾𝑐𝑑𝛾𝑐
𝛾𝑐
0
= 1
2
𝛾𝑐
2𝐺𝑐
′ (4) 
where Ec is the cohesion energy and G’c is the storage modulus at 
critical strain. The cohesion energy is a measurement of the 
energy involved in the formation of physical crosslinks in the 90 
network. The results for CHC/SAL gels with different 
compositions are shown in Table 3. As γc was found to be the 
same for all investigated formulations, differences in the 
calculated cohesion energy were directly correlated to differences 
in shear moduli. Thus the cohesion energies correlate well with 95 
the discussion from moduli values that CHC nanoparticles 
disturbs the SAL-Ca2+ crosslink formation and that Glycerol 
provides crosslinking hydrogen bonds in the composites. 
 In summary the CHC/SAL composite hydrogels exhibits many 
rheological properties making them promising for biomedical 100 
application, especially as implantable depot gels. The 
investigated composites had storage modulus values in the range 
10-30 kPa, which should be easy to adjust further by varying 
parameters such as polymer concentration and gelation medium 
composition. The moduli are of a similar order as reported values 105 
for soft tissue,53-55 which has been stated to be an important factor 
in the host response to implantable devices.5 Furthermore, the 
excellent shear reversibility could allow for direct injection of the 
gels. Under the large shear during injection the gels would be in a 
quasi-liquid state and thus exhibit flow. However, after injection  110 
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Fig. 2 Photographs illustrating the self-healing properties of CHC/SAL 
hydrogels. (a) A sample coloured by Trypan blue and a non-coloured 
sample, both with the weight ratios CHC/SAL/glycerol = 1/1/10, prepared 
by exposure to 2 % w/w CaCl2. A bridge constructed by connecting the 5 
freshly cut surface of the two samples could be (b) suspended horizontally 
and (c) held vertically. 
the shear forces would be absent and the gels would recover to 
the original quasi-solid state.32, 56-58 
Self healing 10 
The ability of a material to self heal damages that occurs during 
use would be highly desirable for materials that are intended to 
perform in a designed manner for significant times where repair 
is not possible.59 For hydrogels used in drug delivery the 
formation of cracks or fractures would increase the surface are 15 
through which drug release occurred, leading to increased release, 
i.e. increased dose per time. In addition, fractures could cause  
unwanted migration and/or altered degradation of implantable 
depot gels.  
 Polymer hydrogels formed by covalent bonds are usually 20 
brittle and lack the ability to self-heal.60 A non-covalent approach 
using dendritic macromolecules as binders in clay nanosheets – 
sodium polyacrylate hydrogels has been reported by Wang et al.61 
The gels were reported to have high mechanical strength, rapid 
shear recovery capability and self healing behaviour, as well as a 25 
very easy preparation procedure. From the excellent shear 
recovery displayed by our composite gels, it was reasoned that 
our dual-structure gels possibly could be self-healing as well. To 
investigate this, gels were prepared in different compositions. It 
was found that no self healing was obtained for pure alginate gels 30 
with or without glycerol, nor did composite gels without glycerol 
exhibit self healing behaviour. However, composite gels with 
high glycerol content could self heal to some extent. This is 
illustrated in Fig. 2, where the freshly cut surfaces of gels of 
different colours (blue and translucent, Fig. 2a) with weight ratios 35 
CHC/SAL/glycerol = 1/1/10 have been brought into contact. The 
healed composite hydrogel was strong enough to hold when 
suspended horizontally (Fig. 2b) and vertically (Fig. 2c). This self 
healing could provide increased durability and robustness of the 
composite gels if used in implant applications. 40 
Equilibrium swelling 
 
Fig. 3 Equilibrium swelling degree of CHC/SAL composite hydrogels 
(weight ratio CHC/SAL/glycerol = 1/1.5/0) as a function of CaCl2 
concentration in gelation medium. Gels were submerged in di-water, 45 
medium (α-MEM) or SBF for 2 days to reach the equilibrium state. Error 
bars indicate Min/Max (n = 3). 
Most biological applications are used in a liquid or semi-liquid 
environment, for swellable materials the swelling is an important 
material parameter which greatly influences mechanical 50 
properties and substance exchange behaviour, i.e. drug release. 
Thus, the equilibrium swelling degree (ESD) of lyophilized 
composite hydrogels with the weight ratios CHC/SAL/glycerol =  
1/1.5/0, prepared using gelation media with different CaCl2 
concentrations, was determined in deionized water (di-water), cell 55 
culture medium (α-MEM+10% FBS), and simulated body fluid 
(1.5SBF). The extent to which a gel swells is determined by the 
swelling pressure (π), which can be written:62-64 
 π = πmix + πion+πe (5) 
where πmix is osmotic pressure from the dissolution of polymer 60 
chains, πion is the osmotic pressure derived from counterions 
within the gel and πe is the elastic pressure derived from the 
deformation of the polymer network during swelling.62-64 The 
term πe in the above equation is determined by the crosslinking 
density, where a high degree of crosslinking corresponds to a 65 
high elastic pressure opposing swelling. For the gels in this study 
the crosslinking should be dominated by the interaction between 
alginate and Ca2+.  
 As expected, it was found that in all investigated swelling 
media the ESD decreased with increasing concentration of CaCl2 70 
in the gelation medium (Fig. 3). Regarding the swelling in 
different media, the swelling was highest in di-water, less in cell 
culture medium and the least in 1.5SBF (Fig. 3). The observed 
values of ESD can be explained by the compositions of the 
different swelling media. In deionized water the contributions of 75 
counterions to the swelling is the highest, i.e. πion is large. In 
contrast for the used α-MEM with a higher and 1.5SBF with the 
highest ionic strength the difference in ion concentration within 
the gel and in the swelling media is reduced, i.e. πion decreases. In 
addition the different compositions of the media could also affect 80 
the interaction parameter, which in turn would influence πmix. 
Furthermore, the α-MEM and 1.5SBF contains divalent ions  
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Fig. 4 Release of all-trans retinoic acid encapsulated in CHC 
nanoparticles loaded in CHC/SAL composite hydrogels with weight 
ratios CHC/SAL = 1/1.5; (a) in di-water and SBF; (b) in di-water with 
different concentrations of calcium chloride used in the gelation medium; 5 
(c) in di-water with different concentrations of glycerol in the prepared 
gels. Error bars indicate min/max (n = 3). 
which are known to act as crosslinkers in alginate.24 Such ions 
would increase the opposing elastic pressure πe in the above 
equation, leading to reduced swelling. Calcium ions replacing 10 
sodium ions of the SAL would also reduce the number of 
counterions within the gel due to their divalent charge. This 
phenomenon with polyvalent ions greatly reducing swelling of 
oppositely charged polymer gels is well described by 
Katchalsky.65 The swelling results show that under conditions 15 
relevant for applications, the swelling is moderate, indicating that 
the gels should maintain good structural integrity and mechanical 
properties. 
In Vitro Drug Release 
As a model drug in release studies all-trans Retinoic acid was 20 
chosen, it is a hydrophobic molecule used in both cancer 
therapy66 and in treatment of dermatological diseases.67 As such it 
is of relevance both for depot implant gels and dermal 
applications. Release profiles from different preparations of 
composite hydrogels in di-water and 1.5SBF are shown in Fig. 4. 25 
During the one week release study, all investigated samples 
displayed similar drug release profiles. All samples released only 
a part of the loaded drug, seemingly reaching a plateau after one 
week. In Fig. 4a the release data for di-water and 1.5SBF is 
shown for hydrogels with the composition of weight ratios 30 
CHC/SAL/glycerol = 1/1.5/0 prepared by exposure to 2 % w/w 
CaCl2. The release of retinoic acid in di-water was much faster 
than in 1.5SBF solution. After one week, 39 % of the drug had 
been released in di-water, to be compared with only 18 % in 
1.5SBF. The release profiles in di-water for gels prepared using 35 
various concentrations of CaCl2 and glycerol is shown in Fig. 4b-
c. The drug release rate increased somewhat with decreasing 
CaCl2 concentration in the gelation medium. After one week the 
released percentage of drug was 43.1 %, from gels prepared using 
1 % w/w CaCl2 gelation medium, 38.5 % using 2 % w/w CaCl2 40 
and only 33.3% using 3 % w/w CaCl2 (Fig. 4b). For glycerol 
there was a slight increase in drug release rate with decreasing 
glycerol content (Fig. 4c). The results demonstrate that the initial 
release rate of retinoic acid from the CHC/SAL composite gels is 
dominated by the release environment, but also affected by gel 45 
composition. To investigate the mechanism of the initial release 
the release data between 0 and about 60 %, as suggested by 
Ritger and Peppas,68 was fitted to the simplified Higuchi equation 
for systems with the loaded drug in the dissolved state:69 
 
𝑀𝑡
𝑀∞
= 2(
𝐷𝑡
𝜋𝑙2
)0.5 (6) 50 
Where Mt/M∞ is the fraction of drug released, here 100 % release 
of the investigated process is assumed to have occurred after 7 
days, D is the drug diffusion coefficient, l is the initial film 
thickness, and t is the release time. The release profiles all 
showed good agreement with diffusion controlled (Fickian 55 
release) and from Eq. 6 the diffusion coefficients for the different 
formulations and conditions were approximated, using a gel 
thickness of 2 mm (Table 4). The calculated D values were of the 
order 10-11 m2s-1, which is similar to previously reported diffusion 
coefficients for dendrimers70 and bovine serum albumin71 in 60 
alginate gels. More specific the calculated D values were all 
rather similar, but with a slight decrease in D for 3 % Ca2+ in the 
gelation medium and a significant increase for release in 1.5SBF  
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Table 4 Diffusion coefficients (10-11m2s-1) and R2 values for the initial 
release from samples with different compositions in deionized water or 
SBF, calculated using Eq. 6. 
 
 
Release 
environment 
% Ca2+ in 
gelation medium 
% glycerol in 
combination 
solution 
 di-water SBF 1% 2% 3% 0% 5% 10% 
D 2.2 4.1 2.5 2.2 1. 5 2.2 1.9 1.9 
R2 0.94 0.98 0.99 0.94 0.99 0.94 0.99 0.97 
 
as compared to in di-water. 5 
 The partial release of drug and the level off in release after one 
week, together with the diffusion controlled mechanism of this 
initial release, indicates that the drug loaded in the composite gels 
is present in two fractions. (1) Drug loaded in the alginate 
hydrogel and in the outer shell of the CHC particles, this being 10 
the fraction initially released by diffusion through the gel matrix.  
 (2) Drug loaded in the CHC nanoparticles, the release of this 
drug fraction would mainly be controlled by the much slower 
release from the CHC nanoparticles. The fact that the drug is 
present in the gels as two fractions is logical. The encapsulation 15 
efficiency of the used CHC is incomplete, and drug loaded CHC 
nanoparticles exhibit burst release of a fraction of the drug within 
one day.36, 44, 72, 73 Thus, when the solution with drug loaded CHC 
was combined with the SAL to form gels, the 15 % of non-loaded 
drug as well as the fraction released during the initial burst 20 
release from the CHC nanoparticles would be freely available for 
release from the composite gels. 
 Interestingly, the amount of drug released in this initial process 
was found to be dependent on gel composition, but even more on 
the release environment, as seen in Fig. 4. This means that the 25 
fraction of drug available for release through the initial faster 
process actually changes. This fact suggests that the amount of 
drug available for fast release can not only be attributed to  
loading efficiency and burst release from the CHC nanoparticles. 
One likely explanation is that there is a complicated phase 30 
behaviour behind the distribution of drug between the phases 
with fast and slow release, and that this distribution changes with 
gel composition, swelling and release environment. 
 The implications of the release characteristics for applications 
would be that the gels hold potential in long term sustained 35 
release, as less than 20 % of the drug is “burst released” in 
1.5SBF. However, a simple washing step should be performed 
prior to injection. For applications where the release should occur 
over a short time, such as one day, the well defined and 
reproducible release profiles of up to about 40 % of the loading 40 
should also be appealing. 
Cytotoxicity evaluation  
To further investigate the potential of the CHC/SAL composites 
in biomedical applications in-vitro cytotoxicity test were 
performed. Cells were cultured on CHC/SAL gel surfaces and 45 
were analyzed using the MTT assay; the results are given in Fig. 
5. The cell viabilities were 96 %, 95 %, and 93 % after 24 hours 
of treatment for pure alginate gels, composite gels and composite 
gels loaded with retinoic acid at a concentration of 100 μg / ml. 
After two days incubation, the cell survival ratios had decreased 50 
for both the pure and drug loaded gels. However, the values of 
the survival ratios were still above 88 %. From the results it can  
 
Fig. 5 Human fibroblast survival ratio after incubation for 24 and 48 
hours on; SAL, CHC/SAL and retinoic acid loaded CHC/SAL hydrogels. 55 
The CHC/SAL gels had the weight ratios CHC/SAL/glycerol = 1/1.5/0 
and the pure SAL gels had a concentration of 1.5 % w/w. Samples were 
prepared by exposure to 2 % w/w CaCl2 gelation medium. Error bars 
indicate min/max (n = 8). 
be concluded that native and drug loaded composite gels 60 
exhibited low cytotoxicity, similar to pure alginate gels. 
In Vivo Primary Irritation Evaluation 
In order to evaluate if the SAL/CHC composite hydrogels caused 
primary skin irritation, the Draize model was utilized. Gel 
samples with high and low dose of sodium alginate were 65 
investigated using healthy male New Zealand White rabbits. The 
result revealed that there was no irritation was detected for any of 
the investigated gel formulations, i.e. the PII values were 0 for 
composite gels with both low and high dose of SAL. Based on 
the results of this in vivo investigation, the irritation properties of 70 
CHC/SAL composite gels show excellent skin contact properties, 
holding promises for use in dermal applications. 
Conclusions 
A stable sodium alginate – amphiphilic chitosan combination 
solution was successfully prepared and utilized to form a novel 75 
dual-structure hybrid hydrogel, composed of nano-structured 
CHC embedded in an alginate matrix. The characterization of the 
composite gels with regard to rheological properties, swelling, 
drug delivery, toxicity and skin irritation revealed that the gels 
held many material properties making them attractive candidates 80 
for biomedical applications, such as; high loading of hydrophobic 
drug, rapid gelling, shear reversibility, well defined drug release, 
low toxicity etc. Combined, the properties make the CHC/SAL 
gels especially good candidates for use as drug delivery platforms 
in long term injectable depot gels or dermal applications. Future 85 
outlook would be to perform long term release studies and 
evaluate different therapeutic applications in vivo. 
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